Cluster 209: progression disease evidence therapy documented prior treatment patients months study 
Cluster 868: treated adequately disease evidence felt malignancy recurrence intent lentigo low 
Cluster 1426: recurrence local therapy disease progression evidence patients cancer radiation treatment 
Cluster 1593: suitable intent curative administered local therapy disease urothelial cancer carcinoma